Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
60 participants
OBSERVATIONAL
2022-02-28
2022-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Left Ventricular unLoading by Impella vs Intra-aortic Balloon Pump
NCT06645990
ExtraCorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock
NCT02301819
Rapid Response VA-ECMO in Refractory Out-of-hospital Cardiac Arrest
NCT03658759
Extracorporeal Life Support in Cardiogenic Shock
NCT03637205
The Application of Negative Atrioventricular Hysteresis in Cardiac Resynchronization Therapy With MultiPoint Pacing
NCT02782598
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
VA-ECMO
Patients who were treated with veno-arterial extracorporeal membrane oxygenation (VA-ECMO) during cardiac arrest.
VA-ECMO
Treatment with veno-arterial extracorporeal membrane oxygenation
ECMELLA
Patients who were treated with veno-arterial extracorporeal membrane oxygenation (VA-ECMO) and Impella® micro-axial pump.
ECMELLA
Treatment with veno-arterial extracorporeal membrane oxygenation plus Impella® micro-axial pump.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
VA-ECMO
Treatment with veno-arterial extracorporeal membrane oxygenation
ECMELLA
Treatment with veno-arterial extracorporeal membrane oxygenation plus Impella® micro-axial pump.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Cardiac arrest
* Treatment with veno-arterial extracorporeal membrane oxygenation (VA-ECMO) or "ECMELLA" (that is VA-ECMO plus left ventricular Impella® micro-axial pump)
Exclusion Criteria
* No treatment with VA-ECMO or "ECMELLA"
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Charite University, Berlin, Germany
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Carsten Skurk
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carsten Skurk, MD
Role: PRINCIPAL_INVESTIGATOR
Charite University
Tharusan Thevathasan, MD
Role: PRINCIPAL_INVESTIGATOR
Charite University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Charité - Universitätsmedizin Berlin
Berlin, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ECMELLA vs. ECMO
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.